Plus   Neg

Haemonetics Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter on Friday, healthcare company Haemonetics Corp. (HAE) raised its adjusted earnings guidance for the full-year 2020, while reaffirming annual revenue growth outlook.

For fiscal 2020, the company raised its adjusted earnings guidance to a range of $3.10 to $3.20 per share from the prior forecast range of $2.95 to $3.15 per share, while continuing to project annual revenue growth in the range of 3 to 5 percent. Organic revenue growth is now expected to be 6 to 8 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $3.06 per share on revenue growth of 4.1 percent to $1.01 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Biotechnology company Seattle Genetics, Inc. (SGEN) and Japanese pharmaceutical company Astellas Pharma Inc. (ALPMY, ALPMY) announced Friday that a phase 3 trial of PADCEV (enfortumab vedotin-ejfv) met its primary endpoint of overall survival compared to chemotherapy. The results were reviewed by... MWE Investments is recalling dual fuel portable generators citing fire risk, according to the U.S. Consumer Product Safety Commission. The recall involves about 7,500 units of Westinghouse WGen5300DFv Dual Fuel Portable Generators and Westinghouse iGen4500DF Dual Fuel Inverter Portable Generators. According to the agency, the dual fuel portable generators can leak fuel. Apple Inc. (AAPL) will launch an online store in India on September 23, offering the tech giant's full range of products and support directly to customers across the country for the first time.
Follow RTT